|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
1.230 0.000 (0.000%) | 2025/12 - Final HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 283,292 | 283,120 | 361,154 | 164,864 | 144,401 |
| Net Cash from / (used in) Investing Activities | (142,587) | (174,718) | (245,371) | (195,695) | (395,730) |
| Net Cash from / (used in) Financing Activities | (221,276) | (194,916) | (242,877) | 293,679 | 85,123 |
| Increase / (Decrease) in Cash & Cash Equivalents | (80,571) | (86,514) | (127,094) | 262,848 | (166,206) |
| Cash & Cash Equivalents at beginning of period | 423,083 | 512,762 | 644,698 | 386,659 | 553,934 |
| Effect of Foreign Exchange Rate Changes | 5,359 | (3,165) | (4,842) | (4,809) | (1,069) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 347,871 | 423,083 | 512,762 | 644,698 | 386,659 |
| Remarks: | Real time quote last updated: 30/04/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 100,366 |
| %Change | -- |
| EPS / (LPS) | HKD 0.083 |
| NBV Per Share ($) | HKD 1.464 |